Skip to search formSkip to main contentSkip to account menu

Platelet Activating Factor

Known as: platelet activating factor (PAF), 1 Alkyl 2 acetyl sn glycerophosphocholine, Thrombocyte Aggregating Activity 
A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1995
Review
1995
ConclusionsThe great number of PAF antagonists reviewed in this article clearly shows the tremendous effort made in the last 20… 
Highly Cited
1989
Highly Cited
1989
Luminal epithelial projections formed during bronchoconstriction define interstices in which liquid can collect. Liquid in these… 
Highly Cited
1986
Highly Cited
1986
Peritoneal cells from thioglycollate-stimulated mice were allowed to adhere to coverglasses for 2 h to give a dense monolayer of… 
Highly Cited
1984
Highly Cited
1984
1-O-[3H]Alkyl-2-lyso-sn-glycero-3-phosphocholine (1-O-[3H]alkyl-2-lyso-GPC) incubated with human polymorphonuclear leukocytes… 
Highly Cited
1983
Highly Cited
1983
1 Paf‐acether (platelet‐activating factor) is a phospholipid capable of stimulating platelets to release their granular contents… 
Highly Cited
1981
Highly Cited
1981
The origin of platelet activating factor (PAF) from human leucocytes was investigated. Purified monocytes release PAF passively… 
Highly Cited
1981
Highly Cited
1981
Summary. The plasma of two patients with heparin‐induced thrombocytopenia has been shown to cause platelet aggregation in the… 
Highly Cited
1980
Highly Cited
1980
Platelet‐activating factor is a 1.0‐alkyl‐2 acetyl analogue of phosphatidylcholine (PAF‐acether) which triggers platelet…